A company with 10 or 20 employees may already manage significant external spend across CROs, CDMOs, laboratories, consultants and specialist service providers.
So what is the best procurement software for a small biotech?
There is no single best platform. The right choice depends primarily on what your company buys and where your procurement complexity sits.
If most of your spend is tied to CROs, CDMOs, consultants and other long-running service agreements, you may need strong contract, commitment, purchase-order and invoice visibility.
If your scientists mainly purchase laboratory supplies and equipment, supplier catalogues, product search and ordering may matter more.
And if you operate a complex global procurement organization, a broader enterprise source-to-pay platform may be appropriate.
Start with the problem – not the feature list.
Which procurement software should a small biotech consider?
Different platforms solve different procurement problems.
| Your main challenge | What to prioritize | Example platforms |
|---|---|---|
| CRO, CDMO and service commitments | Contracts, change orders, POs, approvals and invoices | biosuite |
| Broad life-science procure-to-pay | Requisitions, ordering, receiving, invoices and payments | Prendio |
| Lab supplies and scientific equipment | Product search, supplier catalogues and ordering | ZAGENO |
| External scientific services | Supplier discovery, sourcing and project procurement | Science Exchange |
| Complex enterprise procurement | Strategic sourcing, supplier management and global source-to-pay | Coupa, SAP and similar platforms |
These categories overlap. The purpose is not to rank the platforms from best to worst, but to identify which type of system matches the way your biotech actually spends money.
biosuite is built for service-heavy biotech procurement – where spend often starts with a CRO, CDMO or consulting agreement rather than a catalogue order.
Disclosure: biosuite is our product. This is therefore not an independent software ranking. We have included other categories and platforms because biosuite is not the right solution for every biotech company.
Why biotech procurement can be different
Traditional procurement is often imagined as:
Request → purchase order → goods received → invoice
Biotech does not always work like that.
A significant part of external spend may instead involve services such as:
- CRO agreements
- CDMO services
- Preclinical studies
- Specialist laboratories
- Regulatory consultants
- Scientific consultants
- Clinical operations vendors
These purchases often begin with a contract or statement of work.
A CRO agreement, for example, may have an initial contract value, run for 18 or 24 months and later increase through change orders.
Invoices then arrive over time.
That means the relevant financial question is not only:
“How much have we spent?”
It is also:
“How much have we already committed to spend?”
Committed spend and invoiced spend are not the same
Imagine a biotech signs a €1 million agreement with a CRO.
So far, only €200,000 has been invoiced.
The CRO then issues an approved €150,000 change order.
| Item | Amount |
|---|---|
| Original CRO agreement | €1,000,000 |
| Change order | €150,000 |
| Revised contract value | €1,150,000 |
| Invoiced to date | €200,000 |
| Remaining contract value | €950,000 |
The accounting system may provide an excellent view of the €200,000 already recorded.
But management may also want visibility into the larger commercial commitment.
That €950,000 remaining value is not automatically an accounting expense, liability or accrual. Those concepts answer different questions.
But it can still be important for understanding future commitments, cash requirements and runway.
For service-heavy biotech companies, this is why contracts, change orders, purchase orders and invoices are often more useful when they are connected rather than tracked separately.
What is the best system for a small biotech?
Headcount alone is a poor way to choose procurement software.
Consider two biotech companies with 15 employees.
A service-heavy clinical biotech
The company outsources much of its development work and manages several CRO, CDMO and consulting agreements.
Its biggest problem may be understanding:
- current contract values
- approved change orders
- purchase commitments
- invoices received
- remaining contract value
- who approved additional spend
For this company, a service-oriented procurement and spend-management platform may be the best fit.
A lab-heavy research biotech
The company operates its own laboratories and places many orders for reagents, consumables and equipment.
Its priorities may instead be:
- product discovery
- supplier catalogues
- ordering
- receiving
- scientific supplier coverage
A laboratory purchasing platform may be more appropriate.
Both companies have the same headcount.
They need different procurement software.
Where biosuite fits
biosuite is designed specifically for small and growing biotech companies, particularly where a meaningful share of spend goes to services rather than catalogue purchases.
That may include CROs, consultants, laboratories and other external partners.
biosuite connects:
Contracts → change orders → purchase orders → approvals → invoices
This gives teams visibility into both what has already been invoiced and the commitments behind it.
The existing accounting or ERP system remains in place. biosuite is designed to work alongside it rather than replace it.
The principle is simple:
Know what you've committed – before the invoices arrive.
biosuite may be a good fit if:
- You are a small or growing biotech.
- CROs, CDMOs, consultants or other services represent significant spend.
- Contract values change through amendments or change orders.
- Finance wants visibility before all invoices arrive.
- Purchase orders and approvals need more structure.
- Contracts, POs and invoices currently live in different places.
- You want more control without implementing enterprise procurement complexity.
biosuite may not be the right fit if:
- Your primary need is laboratory product search and catalogue purchasing.
- You manage a complex manufacturing supply chain.
- You require extensive global sourcing and supplier-management functionality.
- You need highly customized enterprise procurement workflows.
- You require validated GxP-critical processes.
The objective is not to be the procurement system for every biotech.
It is to solve a specific problem well.
When should a biotech move beyond spreadsheets?
Spreadsheets can work perfectly well in an early-stage company.
The problem begins when the spreadsheet stops being a record and starts becoming a process.
A typical biotech example is that Clinical Operations has one CRO tracker, Finance has another, and the latest change order is buried in an email attachment while invoices sit in the accounting system.
Each source may be correct.
But no single source shows the current commercial position.
Other warning signs include:
- Contracts and invoices are tracked in different places.
- Different departments maintain separate trackers.
- Change orders are difficult to reconcile.
- Purchase approvals live in email.
- Finance regularly asks teams what has already been committed.
- Management reporting requires manual reconciliation.
- Nobody is completely sure which spreadsheet is current.
At that point, procurement software can reduce the amount of manual reconstruction needed to understand external spend.
The goal should not be to introduce procurement bureaucracy.
It should be to add just enough structure to improve control and visibility.
Does procurement software replace an ERP?
Usually not.
The systems solve different parts of the process.
An ERP or accounting platform remains the financial system of record and is naturally strong at recording transactions as they occur.
Procurement software can operate further upstream:
Contract → approval → PO → invoice → accounting
For many biotech companies, the two views are complementary:
| Accounting / ERP view | Procurement & spend view |
|---|---|
| Transactions recorded | Commitments approved |
| Invoices booked | Contracts and POs authorized |
| Historical financial activity | Commercial commitments not yet fully invoiced |
| General ledger perspective | Contract, PO and vendor perspective |
The exact capabilities of an ERP depend on the system and configuration, so this distinction should not be treated as absolute.
But for long-running external-service agreements, the two perspectives can answer different management questions.
The accounting system may answer:
“What has been booked?”
Procurement and spend-management software can help answer:
“What have we already committed to?”
Both views can be valuable.
Does a small biotech need Coupa or SAP?
Not necessarily.
Enterprise procurement platforms can make sense when a company needs global sourcing, extensive supplier management, multiple entities, sophisticated integrations and mature procurement governance.
But a small biotech may have large external commitments without having enterprise procurement complexity.
In that situation, the useful question is not:
“Which system has the most features?”
It is:
“Which system has the capabilities we actually need?”
Buying software for the organization you might become five years from now can make today's processes unnecessarily complicated.
A better principle is:
Choose enough structure for your current complexity, with room to grow.
8 questions to ask procurement software vendors
Before choosing a system, ask:
- Can we track service contracts and purchase orders together?
- Can amendments and change orders update the current contract value?
- Can purchase orders be linked to contracts?
- Can invoices be checked against POs and contracts?
- Can we see committed, invoiced and remaining value?
- Can approval limits reflect our existing authority structure?
- Does the platform work alongside our accounting or ERP system?
- Can we start small without implementing the entire platform at once?
The answers should reflect how your company actually operates – not a generic procurement maturity model.
Frequently asked questions
What is the best procurement software for a small biotech?
There is no universal best platform. A lab-heavy biotech may prioritize product search and ordering, while a service-heavy biotech may prioritize contracts, CRO commitments, change orders and purchase-order control. Larger organizations may require enterprise source-to-pay functionality.
Does a 10-person biotech need procurement software?
Not necessarily. Spend complexity matters more than headcount. A 10-person biotech managing several large CRO or CDMO agreements may need procurement controls earlier than a much larger company with simpler external spend.
What is committed spend in biotech?
Committed spend is a management view of amounts the company has agreed or authorized to spend, for example through contracts, change orders or purchase orders. It is not automatically the same as an accounting expense, liability or accrual.
When should a biotech stop using spreadsheets?
Consider dedicated software when spreadsheets, email and separate systems make it difficult to understand what has been approved, committed, invoiced or remains against vendor agreements.
Is biosuite the best procurement software for every biotech?
No. biosuite is primarily designed for small and growing biotech companies with service-heavy procurement. Companies focused mainly on high-volume lab purchasing, complex manufacturing or enterprise procurement may be better served by another type of platform.
The bottom line
Small biotech companies can have large financial commitments long before they have large teams.
So do not choose procurement software based on headcount or feature count alone.
If the problem is laboratory ordering, optimize for laboratory ordering.
If the problem is scientific sourcing, optimize for sourcing.
If the problem is enterprise procurement, choose an enterprise platform.
And if the problem is that contracts, change orders, purchase orders and invoices make it difficult to understand what your biotech has already committed to spend, choose a system designed around that problem.
The right procurement system should fit the way your biotech actually spends money.